OOIR: Observatory of International Research

Papers

(The H4-Index of Advanced Drug Delivery Reviews is 84. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Gene editing strategies to treat lysosomal disorders: The example of mucopolysaccharidoses	825
Editorial board members	413
Emerging antibiotic alternatives: From antimicrobial peptides to bacteriophage therapies	330
Genome-scale metabolic modelling in antimicrobial pharmacology: Present and future	327
MicroRNAs and their delivery in diabetic fibrosis	297
Tools for computational design and high-throughput screening of therapeutic enzymes	293
MIDD in Japan– Implementations, challenges and opportunities	267
Leveraging the neurosurgical operating room for therapeutic development in NeuroOncology	227
Penetration and translocation of functional inorganic nanomaterials into biological barriers	220
Drug delivery for metabolism targeted cancer immunotherapy	213
Liposomal formulations for treating lysosomal storage disorders	194
In vitro models of the interplay between glioblastoma and blood–brain barrier for stratifying drug efficacy	193
Design, development and clinical translation of CriPec®-based core-crosslinked polymeric micelles	192
Recent advances in endocrine organoids for therapeutic application	180
Emerging strategies to bypass transplant rejection via biomaterial-assisted immunoengineering: Insights from islets and beyond	176
Polymer-based drug delivery systems under investigation for enzyme replacement and other therapies of lysosomal storage disorders	170
Progress on the pathological tissue microenvironment barrier-modulated nanomedicine	166
Opportunities and challenges in delivering biologics for Alzheimer’s disease by low-intensity ultrasound	165
Long-acting inhaled medicines: Present and future	165
Bacterially mediated drug delivery and therapeutics: Strategies and advancements	159
Nanoparticle-neutrophils interactions for autoimmune regulation	158
Nanovaccines with cell-derived components for cancer immunotherapy	153
Models to study basic and applied aspects of lysosomal storage disorders	149
Deciphering albumin-directed drug delivery by imaging	148
Integrating microneedles and sensing strategies for diagnostic and monitoring applications: The state of the art	144

Cell membrane-coated nanoparticles for targeting carcinogenic bacteria	144
Luminescent quantum dots: Synthesis, optical properties, bioimaging and toxicity	143
Editorial Board	134
Editorial/Preface	133
Targeting microbiome, drug metabolism, and drug delivery in oncology	132
Emerging Voices in Drug Delivery – Harnessing and Modulating Complex Biological Systems (Issue 2)	130
Hydrogen sulfide in cancer therapy: Intelligent delivery platforms and synergistic therapeutic paradigms	130
Nanoparticles-mediated ion channels manipulation: From their membrane interactions to bioapplications	128
Biopharmaceutical drug delivery and phototherapy using protein crystals	123
Red to near-infrared carbon dots: synthesis, cellular interactions, drug loading, and therapeutic applications	121
Activatable dual-functional molecular agents for imaging-guided cancer therapy	121
Protein encapsulation of nanocatalysts: A feasible approach to facilitate catalytic theranostics	120
Synthetic biology-guided design and biosynthesis of protein polymers for delivery	118
iPSC-derived T cells and macrophages: Manufacturing and next-generation application approaches	117
3D printing of drug delivery systems enhanced with micro/nano-technology	116
Pulmonary delivery nanomedicines towards circumventing physiological barriers: Strategies and characterization approaches	115
Novel strategies for modulating the gut microbiome for cancer therapy	113
Activatable fluorescent probes for real-time imaging-guided tumor therapy	113
In situ cellular hitchhiking of nanoparticles for drug delivery	112
From cells to subcellular organelles: Next-generation cancer therapy based on peptide self-assembly	111
Exosome- and extracellular vesicle-based approaches for the treatment of lysosomal storage disorders	107
Solid implantable devices for sustained drug delivery	106
Biomarker and therapeutic potential of peripheral extracellular vesicles in Alzheimer’s disease	104
Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers	104
Strategies to develop polymeric microneedles for controlled drug release	103
RNA binding proteins (RBPs) and their role in DNA damage and radiation response in cancer	103
Hurdles in translating science from lab to market in delivery systems for Cosmetics: An industrial perspective	102
Drug delivery using gold nanoparticles	102
Lysosomal therapies and drug delivery strategies: An overview	101
Micro-patterned cell populations as advanced pharmaceutical drugs with precise functional control	101
Convection-enhanced delivery for brain malignancies: Technical parameters, formulation strategies and clinical perspectives	99
Soft nano and microstructures for the photomodulation of cellular signaling and behavior	97
Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies	96
The extracellular matrix of hematopoietic stem cell niches	95
Fit and forget: The future of dental implant therapy via nanotechnology	95
Tumour extravasation of nanomedicine: The EPR and alternative pathways	94
Unignored intracellular journey and biomedical applications of extracellular vesicles	94
Model-informed precision dosing: State of the art and future perspectives	93
Antibody-drug conjugates as multimodal therapies against hard-to-treat cancers	93
Emerging drug delivery systems with traditional routes – A roadmap to chronic inflammatory diseases	93
Tumor microenvironment subtyping in pancreatic ductal adenocarcinoma: New avenues for personalized therapeutic strategies	92
Lipid nanoparticles for targeted delivery of anticancer therapeutics: Recent advances in development of siRNA and lipoprotein-mimicking nanocarriers	92
Engineering complexity in human tissue models of cancer	91
Engineering bacterial membrane nanovesicles for improved therapies in infectious diseases and cancer	90
Nanosensitizer-mediated unique dynamic therapy tactics for effective inhibition of deep tumors	88
Novel drug delivery systems for the management of dry eye	88
Advances in photoactivated carbon-based nanostructured materials for targeted cancer therapy	88
To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives	88
Light sheet fluorescence microscopy for monitoring drug delivery: Unlocking the developmental phases of embryos	88
Miniaturized therapeutic systems for ultrasound-modulated drug delivery to the central and peripheral nervous system	88

Nanobodies: Robust miniprotein binders in biomedicine	87
Corrigendum to “Editorial: Advanced strategies to bridge the gap between inflammation and tissue regeneration” [Adv. Drug Deliv. Rev. 209 (2024) 115328]	86
Preface: Image-assisted organoid research and application	86
Editorial board members	85
Corrigendum to ‘Cell-penetrating peptides in protein mimicry and cancer therapeutics’ [Advanced Drug Delivery Reviews, 180 (2022), 114044]	85
Editorial Board	85
Editorial board members	85
Responsive nanomedicines enhanced by or enhancing physical modalities to treat solid cancer tumors: Preclinical and clinical evidence of safety and efficacy	84
Design principles for construction of DNA-based nanostructures	84
Optical clearing of tissues: Issues of antimicrobial phototherapy and drug delivery	84